Fosamprenavir

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Fosamprenavir Versus Other Protease Inhibitors

Fosamprenavir Expanded Access

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects